脊髓CB2受体激活减轻骨癌痛超敏并改善血-脊髓屏障完整性
该研究在小鼠骨癌痛模型中发现血-脊髓屏障受损,单次鞘内注射CB2R激动剂JWH015可减轻痛觉超敏、修复屏障完整性并抑制胶质细胞活化与促炎因子,效应可被CB2R拮抗剂AM630阻断。
要点
- 骨癌痛小鼠存在血-脊髓屏障破坏,与胶质细胞活化及炎症相关。
- 鞘内注射JWH015可减轻痛觉超敏并改善血-脊髓屏障通透性与结构。
- JWH015降低IL-1β、TNF-α和MMP9水平,效应由CB2R介导。
核心结论
- JWH015通过抑制胶质细胞活化减轻神经炎症、维持血-脊髓屏障完整性,从而缓解骨癌痛超敏。
- 该研究揭示JWH015治疗骨癌痛的新镇痛机制,为靶向血-脊髓屏障的药物探索提供方向。
研究设计与样本
- 采用雄性小鼠骨癌痛模型,随时间测量痛觉超敏。
- 通过伊文思蓝染料外渗、透射电镜和Western blotting评估血-脊髓屏障通透性与结构完整性。
- 用免疫荧光和Western blotting检测胶质细胞活化及促炎因子水平。
主要发现
- 单次鞘内注射JWH015改善痛觉超敏、血-脊髓屏障破坏及小胶质细胞和星形胶质细胞活化。
- JWH015部分恢复ZO-1和claudin-5表达下降。
- JWH015降低促炎细胞因子白细胞介素-1β和肿瘤坏死因子-α及酶MMP9水平。
- 上述效应均被CB2R选择性拮抗剂AM630预处理所阻断。
临床怎么用
- 鞘内CB2R激动可能成为骨癌痛镇痛并保护血-脊髓屏障的潜在策略。
- CB2R效应可被AM630阻断,提示需关注受体选择性。
局限性
- 研究为雄性小鼠骨癌痛模型,结论外推需谨慎。
- 原文未报告剂量、样本量及P值等具体数值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Disruption of the blood-spinal cord barrier (BSCB) can facilitate inflammation that results in pain hypersensitivity. Proinflammatory cytokines produced by activated microglia and astrocytes damage the BSCB. This study aims to explore whether the BSCB is damaged in the bone cancer pain (BCP) model and to investigate a potential role and mechanism of JWH015 ((2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenylmethanone), a selective cannabinoid receptor 2 (CB2R) agonist, in preserving the BSCB integrity in the BCP model. METHODS: We used a male mouse model of BCP. Pain hypersensitivity was measured over time. Evans blue dye extravasation, transmission electron microscopy and Western blotting were performed to investigate the permeability and structural integrity of the BSCB. Immunofluorescence staining and western blotting were used to investigate the effect of JWH015 on the activation of glial cells and the levels of proinflammatory cytokines. RESULTS: A single intrathecal injection of JWH015 ameliorated pain hypersensitivity, the BSCB disruption and microglia and astrocyte activation. Decreases in the expression of ZO-1 and claudin-5 were partially restored by JWH015. The levels of the proinflammatory cytokines interleukin-1β and tumor necrosis factor-α and the enzyme MMP9 were reduced by JWH015. However, all effects were prevented by pretreatment with a CB2R-selective antagonist, AM630 ((6-iodo-2-methyl-1-(2-morpholinoethyl)-1H-indol-3-yl)(4-methoxyphenyl)methanone). CONCLUSIONS: JWH015 alleviates neuroinflammation and maintains the BSCB integrity and permeability in a mouse model of BCP, which is probably mediated by inhibiting glial cells activation. This study reveals the new analgesic mechanism of JWH015 on BCP and provides a perspective to explore novel drugs that target the BSCB to control BCP.
引用
- Wang C, Xu K, Wang Y, et al. Spinal cannabinoid receptor 2 activation reduces hypersensitivity associated with bone cancer pain and improves the integrity of the blood-spinal cord barrier. Reg Anesth Pain Med. 2020. PMID: 32796132. doi:10.1136/rapm-2019-101262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。